Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

SyntheticMR

0.97 SEK

-1.02 %

Less than 1K followers

SYNT

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.02 %
+14.12 %
-25.38 %
-21.75 %
-54.38 %
-76.26 %
-96.43 %
-97.73 %
-52.98 %

SyntheticMR is a medical technology company that is active in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that aims to increase the efficiency and quality of MRI examinations. The company was founded in 2007 and is headquartered in Linköping.

Read more
Market cap
86.65M SEK
Turnover
13.56K SEK
Revenue
57.05M
EBIT %
-86.45 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/5
2026

Interim report Q1'26

27/5
2026

General meeting '26

25/8
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release4/9/2026, 6:01 AM

SyntheticMR AB: SyntheticMR publishes Annual Report for 2025

SyntheticMR
Regulatory press release4/9/2026, 6:00 AM

SyntheticMR AB: SyntheticMR publicerar årsredovisningen för 2025

SyntheticMR
Regulatory press release4/7/2026, 1:46 PM

Change of date for the Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/7/2026, 1:44 PM

Ändrat datum för årsstämma i SyntheticMR AB (publ)

SyntheticMR
Regulatory press release2/11/2026, 3:51 PM

SyntheticMR AB: SyntheticMR's rights issue has been registered - conversion of BTA into shares

SyntheticMR
Regulatory press release2/11/2026, 3:50 PM

SyntheticMR AB: SyntheticMR:s företrädesemission är registrerad - omvandling av BTA till aktier

SyntheticMR
Regulatory press release2/6/2026, 7:30 AM

SyntheticMR AB: Year-End report January - December 2025

SyntheticMR
Regulatory press release2/6/2026, 7:29 AM

SyntheticMR AB: Bokslutskommuniké januari - december 2025

SyntheticMR
Regulatory press release2/4/2026, 2:16 PM

SyntheticMR AB: SyntheticMR publishes the outcome of the rights issue

SyntheticMR
Regulatory press release2/4/2026, 2:14 PM

SyntheticMR AB: SyntheticMR offentliggör utfall i företrädesemissionen

SyntheticMR
Press release1/20/2026, 6:19 AM

Today the subscription period commences in SyntheticMR AB's rights issue

SyntheticMR
Press release1/20/2026, 6:17 AM

Idag inleds teckningsperioden i SyntheticMR AB:s företrädesemission

SyntheticMR
Regulatory press release1/19/2026, 12:51 PM

SyntheticMR AB publishes information document regarding the rights issue

SyntheticMR
Regulatory press release1/19/2026, 12:50 PM

SyntheticMR AB offentliggör informationsdokument avseende företrädesemission

SyntheticMR
Regulatory press release1/19/2026, 7:48 AM

SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue

SyntheticMR
Regulatory press release1/19/2026, 7:47 AM

SyntheticMR AB offentliggör finansiell guidning inför förestående företrädesemission

SyntheticMR
Press release1/16/2026, 8:15 AM

SyntheticMR AB: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR's Position with a Broader Neuroimaging Offering

SyntheticMR
Press release1/16/2026, 8:15 AM

SyntheticMR AB: Regulatoriskt godkännande för ARIA-monitorering stärker SyntheticMRs position som en ledande aktör inom neurodiagnostik med ett bredare erbjudande

SyntheticMR
Press release1/15/2026, 7:46 AM

SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue

SyntheticMR
Press release1/15/2026, 7:44 AM

SyntheticMR AB meddelar avsikt att publicera finansiell guidning inför förestående företrädesemission

SyntheticMR
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.